Literature DB >> 7575739

Methotrexate as a steroid-sparing agent in Cogan's syndrome: comment on the concise communication by Richardson.

J Pouchot, P Vinceneux, D Bouccara, O Sterkers, B Bodelet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7575739     DOI： 10.1002/art.1780380936

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  3 in total

1.  Low-dose oral methotrexate for the management of childhood Cogan's syndrome: a case report.

Authors:  Yuzaburo Inoue; Takuya Tomemori; Shuichi Suzuki; Takayasu Arima; Minako Tomiita; Naoki Shimojo; Yoichi Kohno
Journal:  Clin Rheumatol       Date:  2007-07-05       Impact factor: 2.980

2.  Interstitial Keratitis, Vertigo, and Vasculitis: Typical Cogan's Syndrome.

Authors:  Ahad Azami; Nasrollah Maleki; Mohammadreza Kalantar Hormozi; Zahra Tavosi
Journal:  Case Rep Med       Date:  2014-03-04

Review 3.  Optimal management of Cogan's syndrome: a multidisciplinary approach.

Authors:  Vittorio D'Aguanno; Massimo Ralli; Marco de Vincentiis; Antonio Greco
Journal:  J Multidiscip Healthc       Date:  2017-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.